ResMed PE Ratio 2006-2019 | RMD

Current and historical p/e ratio for ResMed (RMD) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ResMed PE ratio as of May 24, 2019 is 31.20.
ResMed PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-05-24 113.89 36.98
2019-03-31 103.97 $3.08 33.76
2018-12-31 113.43 $3.11 36.47
2018-09-30 114.50 $2.32 49.35
2018-06-30 102.47 $2.19 46.79
2018-03-31 97.07 $2.14 45.36
2017-12-31 83.17 $2.00 41.59
2017-09-30 75.26 $2.47 30.47
2017-06-30 75.78 $2.41 31.45
2017-03-31 69.70 $2.29 30.44
2016-12-31 59.81 $2.30 26.00
2016-09-30 62.09 $2.40 25.87
2016-06-30 60.31 $2.43 24.82
2016-03-31 54.86 $2.45 22.39
2015-12-31 50.68 $2.46 20.60
2015-09-30 47.85 $2.46 19.45
2015-06-30 52.64 $2.47 21.31
2015-03-31 66.71 $2.47 27.01
2014-12-31 51.87 $2.46 21.09
2014-09-30 45.34 $2.42 18.74
2014-06-30 46.34 $2.40 19.31
2014-03-31 40.71 $2.29 17.78
2013-12-31 42.65 $2.24 19.04
2013-09-30 47.62 $2.17 21.94
2013-06-30 40.48 $2.10 19.28
2013-03-31 41.44 $2.13 19.46
2012-12-31 37.01 $1.99 18.60
2012-09-30 35.88 $1.88 19.08
2012-06-30 27.54 $1.72 16.01
2012-03-31 27.28 $1.56 17.49
2011-12-31 22.42 $1.46 15.36
2011-09-30 25.41 $1.41 18.02
2011-06-30 27.32 $1.44 18.97
2011-03-31 26.48 $1.41 18.78
2010-12-31 30.58 $1.39 22.08
2010-09-30 28.96 $1.32 22.02
2010-06-30 26.84 $1.23 21.82
2010-03-31 28.09 $1.19 23.71
2009-12-31 23.07 $1.13 20.51
2009-09-30 19.95 $1.05 19.09
2009-06-30 17.98 $0.95 18.92
2009-03-31 15.60 $0.85 18.46
2008-12-31 16.54 $0.78 21.21
2008-09-30 18.98 $0.73 26.00
2008-06-30 15.77 $0.71 22.37
2008-03-31 18.62 $0.69 26.98
2007-12-31 23.18 $0.40 57.96
2007-09-30 18.92 $0.42 45.59
2007-06-30 18.21 $0.42 43.36
2007-03-31 22.23 $0.40 56.28
2006-12-31 21.72 $0.67 32.67
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $16.331B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $135.807B 26.36
Medtronic (MDT) Ireland $124.767B 17.82
Stryker (SYK) United States $68.939B 24.60
Boston Scientific (BSX) United States $53.498B 25.65
Baxter (BAX) United States $38.314B 24.15
Zimmer Biomet Holdings (ZBH) United States $23.454B 15.07
Smith & Nephew SNATS (SNN) United Kingdom $18.518B 0.00
Canopy Growth (CGC) Canada $15.286B 0.00
Bio-Rad Laboratories (BIO) United States $8.742B 46.35
Aurora Cannabis (ACB) Canada $8.427B 83.10
Hill-Rom Holdings (HRC) United States $6.498B 19.70
Insulet (PODD) United States $6.479B 472.04
Perrigo (PRGO) Ireland $6.439B 10.89
GW Pharmaceuticals (GWPH) United Kingdom $5.538B 0.00
Haemonetics (HAE) United States $5.172B 42.26
ICU Medical (ICUI) United States $4.652B 27.76
Hutchison China MediTech (HCM) China $3.574B 0.00
NuVasive (NUVA) United States $3.193B 26.07
Neogen (NEOG) United States $2.975B 48.36
Agios Pharmaceuticals (AGIO) United States $2.838B 0.00
National Vision Holdings (EYE) United States $2.257B 48.10
Quidel (QDEL) United States $2.184B 22.66
Aphria (APHA) $1.843B 0.00
Cardiovascular Systems (CSII) United States $1.376B 790.40
Phibro Animal Health (PAHC) United States $1.203B 18.02
AtriCure (ATRC) United States $1.140B 0.00
VAREX IMAGING (VREX) United States $1.042B 22.11
NanoString Technologies (NSTG) United States $0.973B 0.00
Lantheus Holdings (LNTH) United States $0.960B 25.50
MacroGenics (MGNX) United States $0.920B 0.00
Omeros (OMER) United States $0.876B 0.00
PetIQ (PETQ) United States $0.779B 18.92
Eagle Pharmaceuticals (EGRX) United States $0.756B 21.21
Cerus (CERS) United States $0.715B 0.00
TG Therapeutics (TGTX) United States $0.633B 0.00
Surmodics (SRDX) United States $0.572B 83.22
LeMaitre Vascular (LMAT) United States $0.524B 25.35
OraSure Technologies (OSUR) United States $0.509B 23.46
Quanterix (QTRX) United States $0.505B 0.00
Meridian Bioscience (VIVO) United States $0.477B 14.57
Evolus (EOLS) United States $0.440B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.336B 0.00
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.302B 20.93
Vapotherm (VAPO) United States $0.284B 0.00
Rockwell Medical (RMTI) United States $0.272B 0.00
Zynex (ZYXI) United States $0.230B 23.80
Owens & Minor (OMI) United States $0.219B 4.64
Cytosorbents (CTSO) United States $0.213B 0.00
Bovie Medical (APYX) United States $0.198B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Fonar (FONR) United States $0.130B 6.83
Chembio Diagnostics (CEMI) United States $0.120B 0.00
BRAINSWAY LTD (BWAY) Israel $0.118B 0.00
Female Health (VERU) United States $0.112B 0.00
Surface Oncology (SURF) United States $0.107B 0.00
United-Guardian (UG) United States $0.091B 20.10
Neurotrope (NTRP) United States $0.091B 0.00
Insys Therapeutics (INSY) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.056B 19.33
Oramed Pharmaceuticals (ORMP) United States $0.051B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.028B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Akers Biosciences Inc (AKER) United States $0.008B 0.00
NeuroMetrix (NURO) United States $0.006B 4.57